Literature DB >> 9461515

Presence of dopa and amino acid hydroperoxides in proteins modified with advanced glycation end products (AGEs): amino acid oxidation products as a possible source of oxidative stress induced by AGE proteins.

S Fu1, M X Fu, J W Baynes, S R Thorpe, R T Dean.   

Abstract

Glycation and subsequent Maillard or browning reactions of glycated proteins, leading to the formation of advanced glycation end products (AGEs), are involved in the chemical modification of proteins during normal aging and have been implicated in the pathogenesis of diabetic complications. Oxidative conditions accelerate the browning of proteins by glucose, and AGE proteins also induce oxidative stress responses in cells bearing AGE receptors. These observations have led to the hypothesis that glycation-induced pathology results from a cycle of oxidative stress, increased chemical modification of proteins via the Maillard reaction, and further AGE-dependent oxidative stress. Here we show that the preparation of AGE-collagen by incubation with glucose under oxidative conditions in vitro leads not only to glycation and formation of the glycoxidation product Nepsilon-(carboxymethyl)lysine (CML), but also to the formation of amino acid oxidation products on protein, including m-tyrosine, dityrosine, dopa, and valine and leucine hydroperoxides. The formation of both CML and amino acid oxidation products was prevented by anaerobic, anti-oxidative conditions. Amino acid oxidation products were also formed when glycated collagen, prepared under anti-oxidative conditions, was allowed to incubate under aerobic conditions that led to the formation of CML. These experiments demonstrate that amino acid oxidation products are formed in proteins during glycoxidation reactions and suggest that reactive oxygen species formed by redox cycling of dopa or by the metal-catalysed decomposition of amino acid hydroperoxides, rather than by redox activity or reactive oxygen production by AGEs on protein, might contribute to the induction of oxidative stress by AGE proteins.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9461515      PMCID: PMC1219132          DOI: 10.1042/bj3300233

Source DB:  PubMed          Journal:  Biochem J        ISSN: 0264-6021            Impact factor:   3.857


  38 in total

1.  The advanced glycation end product, Nepsilon-(carboxymethyl)lysine, is a product of both lipid peroxidation and glycoxidation reactions.

Authors:  M X Fu; J R Requena; A J Jenkins; T J Lyons; J W Baynes; S R Thorpe
Journal:  J Biol Chem       Date:  1996-04-26       Impact factor: 5.157

2.  N epsilon-(carboxymethyl)lysine is a dominant advanced glycation end product (AGE) antigen in tissue proteins.

Authors:  S Reddy; J Bichler; K J Wells-Knecht; S R Thorpe; J W Baynes
Journal:  Biochemistry       Date:  1995-08-29       Impact factor: 3.162

Review 3.  Biochemistry and pathology of radical-mediated protein oxidation.

Authors:  R T Dean; S Fu; R Stocker; M J Davies
Journal:  Biochem J       Date:  1997-05-15       Impact factor: 3.857

4.  N (epsilon)-(carboxymethyl)lysine protein adduct is a major immunological epitope in proteins modified with advanced glycation end products of the Maillard reaction.

Authors:  K Ikeda; T Higashi; H Sano; Y Jinnouchi; M Yoshida; T Araki; S Ueda; S Horiuchi
Journal:  Biochemistry       Date:  1996-06-18       Impact factor: 3.162

5.  Structural identification of valine hydroperoxides and hydroxides on radical-damaged amino acid, peptide, and protein molecules.

Authors:  S Fu; L A Hick; M M Sheil; R T Dean
Journal:  Free Radic Biol Med       Date:  1995-09       Impact factor: 7.376

6.  Mechanism of autoxidative glycosylation: identification of glyoxal and arabinose as intermediates in the autoxidative modification of proteins by glucose.

Authors:  K J Wells-Knecht; D V Zyzak; J E Litchfield; S R Thorpe; J W Baynes
Journal:  Biochemistry       Date:  1995-03-21       Impact factor: 3.162

7.  Pathways of formation of glycoxidation products during glycation of collagen.

Authors:  M C Wells-Knecht; S R Thorpe; J W Baynes
Journal:  Biochemistry       Date:  1995-11-21       Impact factor: 3.162

8.  Protein hydroperoxides can give rise to reactive free radicals.

Authors:  M J Davies; S Fu; R T Dean
Journal:  Biochem J       Date:  1995-01-15       Impact factor: 3.857

9.  Receptor-mediated endocytic uptake of methylglyoxal-modified serum albumin. Competition with advanced glycation end product-modified serum albumin at the advanced glycation end product receptor.

Authors:  M E Westwood; A C McLellan; P J Thornalley
Journal:  J Biol Chem       Date:  1994-12-23       Impact factor: 5.157

10.  Biological fate of amino acid, peptide and protein hydroperoxides.

Authors:  S Fu; S Gebicki; W Jessup; J M Gebicki; R T Dean
Journal:  Biochem J       Date:  1995-11-01       Impact factor: 3.857

View more
  6 in total

1.  Novel inter-protein cross-link identified in the GGH-ecotin D137Y dimer.

Authors:  M D Person; K C Brown; S Mahrus; C S Craik; A L Burlingame
Journal:  Protein Sci       Date:  2001-08       Impact factor: 6.725

2.  Histone carbonylation in vivo and in vitro.

Authors:  G T Wondrak; D Cervantes-Laurean; E L Jacobson; M K Jacobson
Journal:  Biochem J       Date:  2000-11-01       Impact factor: 3.857

Review 3.  Advanced glycation end products and vascular structure and function.

Authors:  Georgia Soldatos; Mark Emmanuel Cooper
Journal:  Curr Hypertens Rep       Date:  2006-12       Impact factor: 5.369

Review 4.  Interplay of oxidative, nitrosative/nitrative stress, inflammation, cell death and autophagy in diabetic cardiomyopathy.

Authors:  Zoltán V Varga; Zoltán Giricz; Lucas Liaudet; György Haskó; Peter Ferdinandy; Pál Pacher
Journal:  Biochim Biophys Acta       Date:  2014-07-02

Review 5.  Protein oxidation and peroxidation.

Authors:  Michael J Davies
Journal:  Biochem J       Date:  2016-04-01       Impact factor: 3.857

Review 6.  Roles of the tyrosine isomers meta-tyrosine and ortho-tyrosine in oxidative stress.

Authors:  Brett R Ipson; Alfred L Fisher
Journal:  Ageing Res Rev       Date:  2016-03-31       Impact factor: 10.895

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.